• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

Abattis Bioceuticals Corp

+ Add to Watchlist

115:GR

0.197 EUR 0.004 1.99%

As of 14:11:28 ET on 10/21/2014.

Snapshot for Abattis Bioceuticals Corp (115)

Open: 0.194 Day's Range: 0.171 - 0.197 Volume: 0
Previous Close: 0.201 52wk Range: 0.140 - 2.000 1-Yr Rtn: -

Stock Chart for 115

No chart data available.
  • 115:GR 0.185
  • 1D
  • 1M
  • 1Y
0.201
Interactive 115 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 115

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 9.38
Shares Outstanding (M) 47.62
30 Day Average Volume 2,855
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/28/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 115

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for 115

Abattis Biologix Corporation researches, develops and manufactures natural botanical formulations to prevent or treat influenza strains in birds, humans and other mammals.

Michael Withrow "Mike"Chairman/President/CEOTerence Fealey "Tim"Advisor:Global Product Dev
More Company Profile & Key Executives for 115

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil